Amos J de Jong

Which decentralised trial activities are reported in clinical trial protocols of drug trials initiated in 2019–2020? A cross-sectional study in ClinicalTrials.gov

H. Gardarsdottir, A. de Boer, M. Zuidgeest, 2022, BMJ Open.

COVID‐19 and the Emerging Regulatory Guidance for Ongoing Clinical Trials in the European Union

G. van Thiel, H. Gardarsdottir, A. de Boer, 2021, Clinical pharmacology and therapeutics.

Predictive Value of Precision-Cut Kidney Slices as an Ex Vivo Screening Platform for Therapeutics in Human Renal Fibrosis

P. Olinga, R. Bank, H. van Goor, 2020, Pharmaceutics.

Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective

G. van Thiel, H. Gardarsdottir, A. de Boer, 2022, Clinical pharmacology and therapeutics.

Ethics review of decentralized clinical trials (DCTs): results of a mock ethics review.

G. van Thiel, M. Zuidgeest, M. Boeckhout, 2022, Drug discovery today.

Decentralised, patient-centric, site-less, virtual, and digital clinical trials? From confusion to consensus.

D. Grobbee, H. Gardarsdottir, M. Zuidgeest, 2023, Drug discovery today.